Supernus Pharmaceuticals Inc (SUPN) — Cash Flow Reinvestment Rate
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $66.52 Million. Explore Supernus Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Supernus Pharmaceuticals Inc Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Supernus Pharmaceuticals Inc across 13 annual periods. Also explore Supernus Pharmaceuticals Inc (SUPN) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Supernus Pharmaceuticals Inc (2009–2025)
Year-by-year capital reinvestment analysis for Supernus Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Supernus Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 6.34x | $299.88 Million | $47.33 Million | $1.34 Million | ▲ +471.6% |
| 2024 | 1.11x | $190.59 Million | $171.95 Million | $725.00K | ▼ -57.0% |
| 2023 | 2.58x | $286.50 Million | $111.08 Million | $551.00K | ▲ +39.1% |
| 2022 | 1.85x | $216.66 Million | $116.83 Million | $412.00K | ▲ +6.7% |
| 2021 | 1.74x | $220.98 Million | $127.13 Million | $2.04 Million | ▼ -11.2% |
| 2020 | 1.96x | $270.98 Million | $138.40 Million | $3.45 Million | ▲ +76.0% |
| 2019 | 1.11x | $159.27 Million | $143.13 Million | $2.74 Million | ▼ -65.2% |
| 2018 | 3.20x | $412.67 Million | $128.99 Million | $844.00K | ▲ +387.3% |
| 2017 | 0.66x | $75.26 Million | $114.64 Million | $2.03 Million | ▲ +155.9% |
| 2016 | 0.26x | $17.14 Million | $66.81 Million | $1.60 Million | ▼ -71.0% |
| 2015 | 0.88x | $28.38 Million | $32.12 Million | $2.10 Million | ▲ +749.8% |
| 2014 | 0.10x | $804.00K | $7.73 Million | $593.00K | ▼ -61.6% |
| 2009 | 0.27x | $714.00K | $2.63 Million | $714.00K | — |